Chicago[email protected] | (312) 564-8709 | v-Card | View Coverage
Benjamin Burnett, PhD, joined Stifel in March of 2018. Based out of the Chicago office, Dr. Burnett is a Vice President, Equity Analyst in the Healthcare sector covering Biotechnology stocks.
Dr. Burnett was previously an Associate Vice President working on the team of Paul Matteis covering small-cap and mid-cap biotechnology companies at Stifel. Prior to coming to Stifel, he held a similar role on Mr. Matteis’ team at Leerink focusing primarily on biotechnology stocks.
Dr. Burnett earned a PhD in Biophysics at Cornell University’s medical college (Weill) where he studied the kinetics of protein synthesis and, in particular, the role that G-proteins play in this process.